Baltimore, MD – Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025
Revenue of $75.1 million, with revenue per active earning coach of $4,664
Independent active earning coaches of 16,100
Net loss of $18.1 million, or $1.65 per diluted share (“EPS”), which includes the tax provision charge to establish a non-cash valuation allowance on the Company’s deferred tax balance of $12.1 million (or $1.10 per diluted share)
Cash, cash equivalents, and investment Securities of $167.3 million and no debt
Full Year 2025
Revenue of $385.8 million
Net loss of $18.7 million, or $1.70 per diluted share, which includes the tax provision charge to establish a non-cash valuation allowance on the Company’s deferred tax balance of $12.1 million (or $1.10 per diluted share)
“As we enter 2026, Medifast is moving from defining its business transformation strategy to executing on a new path to growth, leading to profitability as we become wholly focused on optimal metabolic health,”
said Dan Chard, Chairman and Chief Executive Officer of Medifast.
“In the fourth quarter, we saw coach productivity turn positive year-over-year for the first time since 2022, which has historically been a lead indicator of